On Wednesday, Natco Pharma said that in Nepal, it has launched generic Hepcinat LP which is in the treatment of chronic hepatitis C infection in adults.
The company said in a filing to BSE that NATCO priced its generic medicine, Hepcinat LP, at Rs 25,000 for a bottle of 28 tablets in Nepal.
Hepcinat LP is used in the treatment of chronic hepatitis C (CHC) genotype 1 infection in adults and is a generic version of Ledipasvir and Sofosbuvir combination.
